FDA Adverse Event Malfunction Summary report: N

INFUSOR

MDR report key: 2161341 · Received July 13, 2011

Report

Report Number
6000001-2011-11746
Event Type
Malfunction
Date Received
July 13, 2011
Date of Event
April 1, 2011
Report Date
June 17, 2011
Manufacturer
BAXTER HEALTHCARE - IRVINE
Product Code
MEB
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
NURSE

Narratives

Additional Manufacturer Narrative · 1

(B)(4). THIS DEVICE IS MANUFACTURED FOR DISTRIBUTION OUTSIDE OF THE UNITED STATES AND DOES NOT HAVE A 510K NUMBER. HOWEVER, THIS PRODUCT IS BEING REPORTED BECAUSE IT IS SAME AS OR SIMILAR TO A PRODUCT DISTRIBUTED WITHIN THE U.S. THE DEVICE IS AVAILABLE FOR EVALUATION PER THE CUSTOMER; HOWEVER, THE DEVICE HAS NOT YET BEEN RECEIVED BY BAXTER. SHOULD THE DEVICE AND/OR ANY ADDITIONAL INFORMATION BECOME AVAILABLE, A FOLLOW-UP REPORT WILL BE SUBMITTED.

Additional Manufacturer Narrative · 1

(B)(4). EVALUATION SUMMARY: BAXTER RECEIVED ONE SAMPLE CONTAINING APPROXIMATELY 80 ML OF SOLUTION IN THE BLADDER. THE REPORTED CONDITION OF NO FLOW/NON-DELIVERY WAS NOT CONFIRMED. VISUAL EXAMINATION OF THE DEVICE SHOWED NO SIGNS OF BLOCKAGE THAT COULD HAVE CAUSED THE REPORTED CONDITION. FLOW WAS READILY OBSERVED AT THE LUER. FLOW CONTINUED WITHOUT STOPPING UNTIL THE SOLUTION WAS EMPTIED FROM THE BLADDER. NO SIGNS OF DEFECT WERE NOTED FROM THE SAMPLE. NO REPAIR WAS DONE, AS THIS IS A SINGLE-USE DEVICE WHICH WILL BE DISCARDED. NO OTHER OBSERVATIONS WERE NOTED ON THE UNIT. PER REVIEW OF THE BATCH RECORDS, NO NONCONFORMANCE REPORT WAS DOCUMENTED FOR THIS LOT. ALL RELEASE CRITERIA WERE MET FOR THE BUILD OF THE LOT. BAXTER HAS CONDUCTED A TREND REVIEW AND FOUND THAT SIMILAR REPORTS HAVE BEEN RECEIVED FOR THE REPORTED PROBLEM. BAXTER WILL CONTINUE TO MONITOR SIMILAR REPORTS TO DETERMINE IF FURTHER ACTIONS ARE REQUIRED.

Description of Event or Problem · 1

BAXTER (B)(4) RECEIVED A REPORT THAT A SEVEN-DAY INFUSOR HAD NO FLOW DURING PATIENT USE. THE DEVICE WAS FILLED WITH ROPIVACAINE HYDROCHLORIDE HYDRATE AND FENTANYL CITRATE. THERE WAS PATIENT INVOLVEMENT, BUT NO PATIENT INJURY, MEDICAL INTERVENTION, OR ADVERSE REACTION IS ASSOCIATED WITH THE REPORTED CONDITION. THE SAMPLE IS AVAILABLE. NO ADDITIONAL INFORMATION IS AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 INFUSOR PUMP, INFUSION, ELASTOMERIC MEB BAXTER HEALTHCARE - IRVINE 10B077

Patients

Seq Age Sex Outcome Treatment
1 ROPIVACAINE HYDROCHLORIDE HYDRATE| FENTANYL CITRATE